title: Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104].
authors.affiliation: Center for Drug Development, Northeastern University, Boston, USA. Electronic address: s.ganapathy@neu.edu.
authors.forename: Suthakar
authors.initials: S
authors.lastname: Ganapathy
authors.affiliation: The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China; The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
authors.forename: Ping
authors.initials: P
authors.lastname: Li
authors.affiliation: The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
authors.forename: Johan
authors.initials: J
authors.lastname: Fagman
authors.affiliation: Center for Drug Development, Northeastern University, Boston, USA.
authors.forename: Tianqi
authors.initials: T
authors.lastname: Yu
authors.affiliation: Center for Drug Development, Northeastern University, Boston, USA.
authors.forename: Jean
authors.initials: J
authors.lastname: Lafontant
authors.affiliation: The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
authors.forename: Guojun
authors.initials: G
authors.lastname: Zhang
authors.affiliation: The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
authors.forename: Changyan
authors.initials: C
authors.lastname: Chen